The production of TNFα during chronic inflammation leads to organ damage due to excessive inflammation. As the first in a series of articles exploring the value of tumour necrosis factor inhibitors (anti-TNFs) in treating immune-mediated disease, this review delved into the use of these therapies for inflammatory conditions, analysing their associated safety in pregnancy.
EMJ Gastroenterology 11 [Supplement 3] . 2022
July 2022
In this issue
Latest articles
All articles![](https://www.emjreviews.com/wp-content/uploads/2024/03/NCA-What-is-PEAL-Syndrome-Gast-940x564.png)
![](https://www.emjreviews.com/wp-content/uploads/2023/11/Is-Intestinal-Cell-Death-in-Necrotising-Enterocolitis-Assorted-and-Multifarious-940x564.png)
![](https://www.emjreviews.com/wp-content/uploads/2023/11/Gastro_CaseReport_SAPHO-Syndrome-in-Crohns-Disease-940x564.jpg)
![](https://www.emjreviews.com/wp-content/uploads/2023/11/Gideon-Hirschfield-940x564.png)